pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 607 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    JWATM-204
    Hepatocellular Carcinoma Eureka Therapeutics Inc
  • Phase 2
    Jankistomig
    Solid Tumor Ottimo Pharma Ltd
  • Phase 2
    KB-707
    Metastatic Melanoma$KRYS Krystal Biotech, Inc.
  • Phase 2
← prev
page 7 of 21
next →
131
Pain89
Neurology1
KITE-363
Diffuse Large B-Cell Lymphoma
Kite Pharma Inc
  • Phase 2
    KITE-753
    Diffuse Large B-Cell Lymphoma$GILD GILEAD SCIENCES, INC.
  • Phase 2
    KSQ-001
    Head And Neck Squamous Cell Carcinoma (HNSC) KSQ Therapeutics Inc
  • Phase 2
    KSQ-004
    Acral Lentiginous Melanoma KSQ Therapeutics Inc
  • Phase 2
    LAT-010
    Breast Cancer Latticon Antibody Therapeutics Inc
  • Phase 2
    LB-100
    Myelodysplastic Syndrome (Preleukemia)$LIXT LIXTE BIOTECHNOLOGY HOLDINGS, INC.
  • Phase 2
    LB-2102
    Neuroendocrine Carcinoma$NVS NOVARTIS AG
  • Phase 2
    LCB-71
    Diffuse Large B-Cell Lymphoma CStone Pharmaceuticals Co Ltd
  • Phase 2
    LG-631
    Glioblastoma Multiforme (GBM) Lentigen Technology Inc
  • Phase 2
    LIOCYXM-004
    Hepatocellular Carcinoma Lion TCR Pte Ltd
  • Phase 2
    LM-24C5
    Solid Tumor LaNova Medicines Ltd
  • Phase 2
    LMP-744
    Recurrent Glioblastoma Multiforme (GBM) Gibson Oncology LLC
  • Phase 2
    LNTH-2403
    Osteosarcoma$LNTH Lantheus Holdings, Inc.
  • Phase 2
    LOAd-703
    Pancreatic Ductal Adenocarcinoma Lokon Pharma AB
  • Phase 2
    LP-184
    Central Nervous System (CNS) Cancer Starlight Therapeutics Inc
  • Phase 2
    LXP-109
    Non-Small Cell Lung Cancer LaunXP Biomedical Co Ltd
  • Phase 2
    LXP-5268
    Triple-Negative Breast Cancer (TNBC) LaunXP Biomedical Co Ltd
  • Phase 2
    LYT-200
    Liver Cancer Gallop Oncology Inc
  • Phase 2
    M-032
    Anaplastic Astrocytoma UAB Minority Health and Health Equity Research Center
  • Phase 2
    MB-105
    Cutaneous T-Cell Lymphoma March Biosciences
  • Phase 2
    MC-001
    Spinal Cord Injury StemCyte Inc
  • Phase 2
    MDNA-11
    Solid Tumor$MDNAF Medicenna Therapeutics Corp.
  • Phase 2
    MDX-1097
    Refractory Multiple Myeloma HaemaLogix Pty Ltd
  • Phase 2
    MEDI-0457
    Oropharyngeal Cancer$AZN ASTRAZENECA PLC
  • Phase 2
    MP-0712
    Neuroendocrine Tumors$MOLN MOLECULAR PARTNERS AG
  • Phase 2
    MPB-1734
    Solid Tumor MegaPro Biomedical Co Ltd
  • Phase 2
    MRG-002
    Gastric Cancer Shanghai Miracogen Inc